Compliance
Responsible supply starts before quotation.
Product status depends on the substance, presentation, intended use, buyer and destination. Each requirement is reviewed on those facts.
Pricing and product-specific commercial detail follow business qualification.
Who we supply
PeptidePharmacies is designed for organisations with a legitimate business, institutional or laboratory requirement. Business registration, professional licensing or institutional status is checked before pricing or restricted commercial detail is released. We do not supply individuals or personal-use enquiries.
How product review works
Named sourcing references and compliance-approved product records are different states. An owner-authorised, unclassified name may appear only as a clearly labelled, noindex enquiry aid with no stock, specification, permitted-use or supply claim. Tier 1–2 records may be described as approved only after qualified review. Restricted records remain behind verified-buyer access, and prohibited records do not appear publicly.
Destination checks
No destination is represented as served until the jurisdiction matrix is approved. An enquiry records the intended destination so the team can review the buyer's status, product classification, import requirements, export controls, sanctions and necessary documents together.
What we will not do
- Supply individuals or accept personal-use requests.
- Make therapeutic, performance, efficacy or safety claims.
- Provide dosing, administration or clinical guidance.
- Confirm supply where the buyer or destination requirements are unresolved.
- Misdescribe goods or alter documentation for customs purposes.
Reviewed supply modelLegal-entity, licence and served-market details will be published here only after documentary verification. Their absence is deliberate.